BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 30, 2005
View Archived Issues
TolerRx Raises $31M In Series D To Advance Diabetes Drug TRX4
Less than a year after withdrawing a proposed initial public offering, TolerRx Inc. dipped into the private markets, raising $31 million in a Series D round. (BioWorld Today)
Read More
BioCurex Licenses Biomarker To Abbott In First Significant Deal
Read More
Unlike In Hollywood, Golden Rice Sequel Trumps Original
Read More
Syngenta Subject Of Inquiry Over Unapproved Corn Sales
Read More
Other News To Note
Read More
Appointments And Advancements
Read More